Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tyco Healthcare

This article was originally published in The Gray Sheet

Executive Summary

Tyco unit "is driven by consumables, which makes it extremely stable regardless of the economic environment," CEO Dennis Kozlowski says in April 25 letter to shareholders announcing that the conglomerate has terminated plans to break up the company. Tyco originally announced its intention to split into four separate companies - Healthcare, Security and Electronics, Fire Protection and Flow Control, and Financial Services - in order to increase the value of the firms' stock price and provide increased visibility to investors (1"The Gray Sheet" Jan. 28, 2002, p. 3). Wall Street reacted negatively to the plan, however; the company's stock price has dropped from $45 prior to the announced break-up plan to the $20-range...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016488

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel